TOBINICK EDWARD L has a total of 13 patent applications. Its first patent ever was published in 1999. It filed its patents most often in United States, Australia and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are BOYS TOWN NAT RES HOSPITAL, THERATECHNOLOGIES INC and SAGETIS BIOTECH SL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 3 | |
#3 | WIPO (World Intellectual Property Organization) | 3 | |
#4 | Canada | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Machines | |
#5 | Medical technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Climate change adaptation technologies | |
#5 | Unspecified technologies | |
#6 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Tobinick Edward L | 13 |
#2 | Tobinick Arthur Jerome | 5 |
Publication | Filing date | Title |
---|---|---|
USRE45976E | Methods of inhibiting the action of TNF for neurological conditions by administering etanercept intrathecally | |
US2006051381A1 | Cytokine antagonists for neurological and neuropsychiatric disorders | |
WO0149321A1 | Tnf inhibitors for the treatment of neurological, retinal and muscular disorders | |
NZ514247A | Tumor necrosis factor antagonists for the treatment of neurological disorders | |
AU4196599A | Apparatus and method employing a single laser for removal of hair, veins and capillaries |